血管激素受体阻断剂治疗与中风患者急性发作之间的关联
Zoltán Szupera1, György Czifra1, Bence Fülöp1
1Department of Neurology and Stroke, South-buda Central Hospital, Szent Imre Teaching Hospital, Budapest.
概括
ангиотензин受体阻断剂 (ARB) 治疗可以降低中风后患者急性症状性发作的风险. 这一发现表明ARB疗法的潜在抗发作特性,需要进一步调查.
科学领域:
- 神经学 神经学
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 新出现的证据表明,血管激素受体阻断剂 (ARB) 治疗与风险降低之间存在潜在联系.
- 这种关联的确切机制和患者特征尚不清楚.
研究的目的:
- 调查ARB治疗是否与急性中风患者急性症状性发作的发病率较低有关.
- 为了比较接受ARB治疗的急性中风患者与未接受ARB治疗的患者的发病率.
主要方法:
- 进行了一项单中心,回顾性,观察性横截面研究.
- 分析了1611名急性中风患者,分为ARB治疗和对照组.
- 在中风发作后7天内发生的急性症状性发作是主要结局,使用逻辑回归模型进行评估.
主要成果:
- 与对照组相比,ARB组 (1.70%) 的急性症状发病率明显较低 (5.67%) (P=0.014).与对照组相比,ARB组 (1.70%) 的急性症状发病率明显较低.
- 多变量分析确定ARB疗法是较低发病率的独立预测因素 (OR,0.33;P=0.032),与出血性中风一起是较高发病率的预测因素.
结论:
- 在急性中风患者中,ARB治疗与急性症状性发作的发生率降低有关.
- 这些发现表明ARB疗法的潜在抗发作特性,需要进一步的研究来证实其益处.
相关概念视频
Antiepileptic Drugs: Sodium Channel Blockers
340
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
340
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
209
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
209
Antihypertensive Drugs: Direct Renin Inhibitors
468
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
468
Antiepileptic Drugs: Potassium Channel Activators
140
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
140
Arteries of the Lower Limbs
176
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
176
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
363
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
363


